Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
about
Metabolic insight into mechanisms of high-altitude adaptation in TibetansAn overview of sphingolipid metabolism: from synthesis to breakdownA critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathyCentral role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndromeInsulin resistance is a cellular antioxidant defense mechanismLipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid IntermediatesThe Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for TreatmentInsulin receptor signaling in normal and insulin-resistant statesLinking obesity with type 2 diabetes: the role of T-betDihydroceramides: From Bit Players to Lead ActorsSphingolipid signaling in metabolic disordersOn ceramides, other sphingolipids and impaired glucose homeostasisThe adipokine/ceramide axis: key aspects of insulin sensitizationEffects of fatty acid treatments on the dexamethasone-induced intramuscular lipid accumulation in chickensChronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) RatsDefect of insulin signal in peripheral tissues: Important role of ceramideRegulation of Nlrp3 inflammasome by dietary metabolitesThe cell biology of fat expansionAutophagy regulates sphingolipid levels in the liverMitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistanceBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseThe effects of obesity on skeletal muscle regenerationLong-chain fatty acid combustion rate is associated with unique metabolite profiles in skeletal muscle mitochondriaIncreased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthaseComparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys?Identification of sphingolipid metabolites that induce obesity via misregulation of appetite, caloric intake and fat storage in DrosophilaFam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesisAblation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitroPalmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C θ and εMechanisms for insulin resistance: common threads and missing linksSphingolipids and phospholipids in insulin resistance and related metabolic disorders.Role of ceramide in diabetes mellitus: evidence and mechanisms.Opening of the mitochondrial permeability transition pore links mitochondrial dysfunction to insulin resistance in skeletal muscle.Insulin resistance without elevated mammalian target of rapamycin complex 1 activity in muscles of mice fed a high-fat diet.Exercise dose response in musclePGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammationIL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitisCompensatory increases in nuclear PGC1alpha protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats
P2860
Q24605065-61B56F9D-279D-4C99-9062-44C1DB87063FQ24628769-F331406C-DE31-406F-8F03-F375897199FBQ24634622-436EBFEC-1851-466B-AEED-B72ABADFB24CQ24648112-40B04CA9-8627-4136-896A-509D96355E13Q24650976-01F28D16-9FB2-474E-8003-9C10B1E857D7Q26739957-B5A3B18D-6621-48B4-A9B8-FE0ACB0776B9Q26776377-19F6DF68-0E2A-4BA2-9CE6-D494C1705189Q26823171-2E0BF359-F52C-4EF5-987C-541DDE095C4EQ26830915-B1418ABB-DACC-458E-8DAD-480F29E82EF0Q26851948-F36FD14A-D47E-4780-A79B-B8FA92580408Q26992148-AC8B11C2-7A75-4BE1-A10F-8FF66784AC4EQ27021446-4A08965B-9CD0-463D-9ACB-B8DEC296150BQ27025041-1262A62A-A086-43D7-83FD-BECA35A351A7Q27303384-89D89CEB-4539-40ED-A355-89DF76DD912BQ27316398-29B25917-3B2D-44BE-9D40-10D264E04AC4Q27690875-FCE8953F-E659-400B-8294-7F81E1494478Q28078340-215BF959-03ED-47D8-AF89-DAB3B4FB77DAQ28084054-C5312910-A0A3-4516-9270-E24919C98530Q28115515-6CC32F3B-B107-4C30-8D6F-141D0F7C4AF1Q28253498-3CF2B37A-2E33-49A2-AA52-93C21491ACBCQ28259585-C0F01C79-F71B-4590-A930-A12BF22E0516Q28393087-650FEA8B-70DD-4F53-9248-D0ECBB4CD374Q28473405-293A7B5A-9F51-475E-9D61-691736C45EA1Q28474576-AD17C08C-C805-4BC5-ACA4-58ED2DB4DA0EQ28478051-611894EA-1F6A-481B-9459-C6F8A4922BECQ28536054-4A967FE6-5290-486B-9096-4C3998A18B15Q28589295-336A3065-2321-4C24-9100-4469B0D5297CQ28595077-059B68C8-E698-4DF6-948E-9881CD710D77Q28743444-613FDEE8-E29F-4D84-9EF3-9B0F807B818BQ29620447-CE5C9AD9-BDC2-4262-B97B-9394EB4BEC7BQ30241943-24006C58-50A5-4312-A7E2-AEA5859E13D2Q30351934-FFF0CF3F-DC16-4B35-98FD-D67CDE312970Q30414295-7A862506-3E2A-40B4-9D35-857772378D87Q30417125-0A812650-E093-4643-9683-D4EA2ACEC510Q30417219-C7C12A61-8700-403E-B591-D1F8AEC7EA35Q30431199-6FA19D37-0B72-460A-A218-5F9EAD18675DQ30701525-9BB51939-2E1E-41FE-AEDA-1EB4C33A1E3EQ33420391-5B106A6F-C024-4A69-B5E7-D4113D3A513AQ33516564-86B1C48B-CE6C-40CB-8BFD-64010C5F2659Q33526750-66424E9B-A472-422C-9A70-DBE59EEBEE20
P2860
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@ast
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@en
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@nl
type
label
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@ast
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@en
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@nl
prefLabel
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@ast
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@en
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@nl
P2093
P921
P3181
P1433
P1476
Inhibition of ceramide synthes ...... ity-induced insulin resistance
@en
P2093
Angela Siesky
Don H Nelson
Eric D Hawkins
Greg K Fontenot
Joseph T Brozinick
Katherine M Sargent
Krishna Narra
Li-Ping Wang
Scott A Summers
Sotirios K Karathanasis
P304
P3181
P356
10.1016/J.CMET.2007.01.002
P407
P577
2007-03-01T00:00:00Z